# A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

> **NCT02550873** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 117 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **BIOLOGICAL:** PRM-151
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT02550873
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-01
- **Primary completion:** 2017-05-02
- **Final completion:** 2017-05-02
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2022-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02550873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02550873, "A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02550873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*